NCBiotech Transforms Life Sciences in North Carolina

Be a part of the transformation
Professionals
Companies
Funding Seekers
Economic Developers
Investors

Networking. Training events. Employment opportunities. NCBiotech can connect you with the next job or company you need to advance your career in life sciences.

Careers in the Life Sciences

Company Directory

North Carolina is home to 830 life sciences companies that directly employ 75,000 people. This directory includes those companies as well as 2,500 additional North Carolina companies that support or are related to our thriving sector.

Search Directory

Coming Events

27 Jun

Jun 27 | 6:00 pm-9:00 pm

Latest News

North Carolina-based Advanced Medicine Partners has announced a new financing agreement led by Deerfield Management, with additional support from ARCH Venture Partners and other investors. Once complete, this latest funding round of $32 million will bring the total direct investment in Advanced Medicine Partners to $60 million since its separation from Jaguar Gene Therapy.

Daniel R. Saban, Ph.D., founder and chief scientific officer of Duke University spinout Piximune Therapeutics was honored with the 2024 Cogan Award from the Association for Research in Vision and Ophthalmology (ARVO), the world’s largest association of eye and vision researchers. 

The Foundation Fighting Blindness has awarded Opus Genetics, a Research Triangle Park drug development startup focused on inherited diseases of the retina, $1.7 million in funding to help advance two preclinical therapy candidates.

Whether you have a new company with an idea or an established company looking to grow, NCBiotech will connect you with the resources to transform your business. Find lab spaces, meeting spaces and more.

Business Meeting

Entrepreneur Resources

NCBiotech wants entrepreneurs and startups to thrive in North Carolina.

View Resources
NCBiotech Conference Center

Business Resources

NCBiotech offers meeting spaces as well as analysis and resources needed to inform strategic decisions for your company.
Life Science Intelligence
Conference Center at NCBiotech

Career Center

The NCBiotech Career Center connects the local workforce with North Carolina-based jobs and internships in the life science industry. Whether you're looking to fill roles in R&D, regulatory affairs, business development or beyond, post your open positions and find out why the NCBiotech Career Center is the best place to connect with North Carolina life science talent.

View Career Center

Latest News

North Carolina-based Advanced Medicine Partners has announced a new financing agreement led by Deerfield Management, with additional support from ARCH Venture Partners and other investors. Once complete, this latest funding round of $32 million will bring the total direct investment in Advanced Medicine Partners to $60 million since its separation from Jaguar Gene Therapy.

Daniel R. Saban, Ph.D., founder and chief scientific officer of Duke University spinout Piximune Therapeutics was honored with the 2024 Cogan Award from the Association for Research in Vision and Ophthalmology (ARVO), the world’s largest association of eye and vision researchers. 

The Foundation Fighting Blindness has awarded Opus Genetics, a Research Triangle Park drug development startup focused on inherited diseases of the retina, $1.7 million in funding to help advance two preclinical therapy candidates.

Research grants. Company loans. Financial resources. NCBiotech can link you to the funding you need to make your life sciences innovation a reality.

Researcher

Research Grants

NCBiotech grants fill critical funding gaps along the innovation continuum - from building university infrastructure to supporting early stage development of university inventions to help move technology toward commercialization.

View Grants
Business People

Company Loans

NCBiotech understands the importance of emerging entrepreneurial companies to the state’s life science landscape.

More about loans

Funding Resources

Among the many obstacles between idea and market in life sciences product development, the most daunting is securing capital.

NCBiotech offers several funding programs designed to fill gaps in technology development and company growth. These funds help university researchers and companies conduct critical studies and reach significant development milestones that enable them to attract follow-on funding.

Funding Resources

Latest News

North Carolina-based Advanced Medicine Partners has announced a new financing agreement led by Deerfield Management, with additional support from ARCH Venture Partners and other investors. Once complete, this latest funding round of $32 million will bring the total direct investment in Advanced Medicine Partners to $60 million since its separation from Jaguar Gene Therapy.

Daniel R. Saban, Ph.D., founder and chief scientific officer of Duke University spinout Piximune Therapeutics was honored with the 2024 Cogan Award from the Association for Research in Vision and Ophthalmology (ARVO), the world’s largest association of eye and vision researchers. 

The Foundation Fighting Blindness has awarded Opus Genetics, a Research Triangle Park drug development startup focused on inherited diseases of the retina, $1.7 million in funding to help advance two preclinical therapy candidates.

Our strong cluster thrives from a diverse ecosystem and specialized talent. NCBiotech can show you all the benefits available to you as part of the NC life sciences community.

What makes North Carolina a leading life sciences hub?

Our top-tier research universities, strong talent pipeline, and thriving ecosystem are moving life sciences companies forward.

Why North Carolina

North Carolina Life Sciences 2025

Join the Life Sciences Alliance and grow North Carolina's global leadership.

Learn More

Company Directory

North Carolina is home to 830 life sciences companies that directly employ 75,000 people. This directory includes those companies as well as 2,500 additional North Carolina companies that support or are related to our thriving sector.

Search Directory

Latest News

North Carolina-based Advanced Medicine Partners has announced a new financing agreement led by Deerfield Management, with additional support from ARCH Venture Partners and other investors. Once complete, this latest funding round of $32 million will bring the total direct investment in Advanced Medicine Partners to $60 million since its separation from Jaguar Gene Therapy.

Daniel R. Saban, Ph.D., founder and chief scientific officer of Duke University spinout Piximune Therapeutics was honored with the 2024 Cogan Award from the Association for Research in Vision and Ophthalmology (ARVO), the world’s largest association of eye and vision researchers. 

The Foundation Fighting Blindness has awarded Opus Genetics, a Research Triangle Park drug development startup focused on inherited diseases of the retina, $1.7 million in funding to help advance two preclinical therapy candidates.

NCBiotech keeps its eye on the horizon. Let us introduce you to the life sciences companies with the technologies of tomorrow.

NCBiotech Portfolio

NCBiotech has invested in more than 255 North Carolina life sciences companies through loan and convertible note programs. These investments have led to nearly 50 mergers and acquisitions and IPOs.

Learn More

Emerging Company Development

The Emerging Company Development team invests in early-stage companies through loan programs that help companies reach early milestones and enable them to raise private capital. Additionally, it advises life science companies on business, product development, and fundraising strategy and help entrepreneurs refine their business plans, investor presentations, and financial projections.

Meet the Team

Company Directory

North Carolina is home to 830 life sciences companies that directly employ 75,000 people. This directory includes those companies as well as 2,500 additional North Carolina companies that support or are related to our thriving sector.

Search Directory

Latest News

North Carolina-based Advanced Medicine Partners has announced a new financing agreement led by Deerfield Management, with additional support from ARCH Venture Partners and other investors. Once complete, this latest funding round of $32 million will bring the total direct investment in Advanced Medicine Partners to $60 million since its separation from Jaguar Gene Therapy.

Daniel R. Saban, Ph.D., founder and chief scientific officer of Duke University spinout Piximune Therapeutics was honored with the 2024 Cogan Award from the Association for Research in Vision and Ophthalmology (ARVO), the world’s largest association of eye and vision researchers. 

The Foundation Fighting Blindness has awarded Opus Genetics, a Research Triangle Park drug development startup focused on inherited diseases of the retina, $1.7 million in funding to help advance two preclinical therapy candidates.

Video Credits: Syngenta, NCBiotech: NC Life Science Video, Duke University, Thermo Fisher Scientific, East Carolina University

NCBiotech leads life science economic development for North Carolina. We help advance ideas from research to marketplace, overcoming all of the challenges in between. We are transforming businesses, technologies, professionals and whole sectors related to life science. Our continued mission to support innovation, commercialization, education and business growth has made North Carolina a global life science leader.

scroll back to top of page